Success Story: Thanks to Our Assistance, a Biomedical Engineering Expert Secured NIW Approval Through Direct Premium Processing
Client’s Testimonial:
"The team was professional with timely responses either from the online portal or phone call. I will choose them again if I need to file my EB1 petition.”
On June 6th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Assistant - PhD Student in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Research Assistant - PhD Student
Country of Origin: China
State of Residence at the Time of Filing: Wisconsin
Approval Notice Date: June 6th, 2026
Processing Time: 1 month, 17 days (Premium Processing Requested)
Case Summary:
The client’s work sits at the intersection of biomedical engineering, biomaterials, 3D bioprinting, and tissue engineering. With a master’s degree in biomedical engineering, the client has focused his research on developing novel biomaterials for use with focused ultrasound techniques in 3D bioprinting for osteogenesis. His proposed endeavor was presented as nationally important because it aims to improve tissue engineering approaches that may lower the need for open surgery, reduce repeated procedures, and enhance cell viability during in vivo focused ultrasound bioprinting.
The petition explained that this research responds to a significant healthcare problem rather than a purely technical laboratory goal. Musculoskeletal conditions create a substantial medical and economic burden, and the client’s work on biomaterials and focused ultrasound bioprinting was positioned as part of a broader effort to improve regenerative medicine, cartilage repair, tissue restoration, and patient outcomes. His current research at a U.S. university allows him to continue developing aqueous two-phase biomaterials, focused ultrasound bioprinting systems with machine learning feedback, and tools for measuring acoustic properties of biomaterials.
To show that the client was well-positioned to advance this endeavor, the petition relied on a focused record of scholarly output and peer recognition. The client’s record included 6 peer-reviewed journal articles, including 1 first-authored article, 3 manuscripts under review, 1 abstract, 146 citations, and at least 15 completed peer reviews. Rather than presenting these figures as automatically persuasive, the petition explained how they would likely be interpreted in context. The publications showed a developing but highly relevant research portfolio in biomaterials and bioprinting, the citations reflected independent use of his findings by other researchers, and the peer-review invitations demonstrated that journals trusted his expertise to evaluate work in biomedical engineering and related fields.
The petition further demonstrated the client’s significance by showing how other researchers had relied on his work involving gelatin-based hydrogels, osteochondral tissue engineering, multimaterial bioprinting, tissue-specific scaffolds, and 4D printing applications in healthcare. North America Immigration Law Group connected these examples to show that the client’s contributions had practical value beyond publication, especially for improving biocompatible materials, printing fidelity, and tissue engineering strategies relevant to regenerative medicine.
The case was also supported by 4 letters of recommendation from experts in the field, including independent experts. These letters helped explain the client’s technical role in advancing biomaterials and focused ultrasound bioprinting, while also connecting his research record to the broader need for less invasive and more effective approaches to musculoskeletal treatment.
With direct premium processing requested, the client’s I-140 NIW petition was approved in 47 days. This approval reflects the successful presentation of a case grounded in biomedical engineering expertise, applied biomaterials research, independent scholarly reliance, peer recognition, and the national importance of advancing tissue engineering technologies that may improve patient care and reduce healthcare burdens in the United States.